Insider Transactions in Q3 2025 at Durect Corp (DRRX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2025
|
Judith J. Robertson |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
41,113
-100.0%
|
-
|
|
Sep 11
2025
|
James E Brown President & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
96,959
-100.0%
|
-
|
|
Sep 11
2025
|
James E Brown President & CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
8,000
-100.0%
|
-
|
|
Sep 11
2025
|
James E Brown President & CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
448,376
-100.0%
|
-
|
|
Sep 11
2025
|
Gail M Farfel |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,500
-100.0%
|
-
|
|
Sep 11
2025
|
Norman Sussman Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,425
-100.0%
|
-
|
|
Sep 11
2025
|
Gail J Maderis |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
20,000
-100.0%
|
-
|
|
Sep 11
2025
|
Gail J Maderis |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,500
-100.0%
|
-
|
|
Sep 11
2025
|
Mohammad Azab |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
6,000
-100.0%
|
-
|
|
Sep 11
2025
|
Peter S Garcia |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
12,500
-100.0%
|
-
|
|
Sep 11
2025
|
Timothy M. Papp Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,659
-100.0%
|
-
|
|
Sep 11
2025
|
Timothy M. Papp Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
385,000
-100.0%
|
-
|
|
Sep 10
2025
|
Gail M Farfel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+26.19%
|
$5,500
$1.22 P/Share
|
|
Sep 10
2025
|
Judith J. Robertson |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+11.8%
|
$5,500
$1.22 P/Share
|
|
Sep 10
2025
|
James E Brown President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
130,000
+19.25%
|
$130,000
$1.3 P/Share
|
|
Sep 09
2025
|
James E Brown President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
131,923
+24.11%
|
$131,923
$1.3 P/Share
|
|
Sep 09
2025
|
Peter S Garcia |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+30.56%
|
$5,500
$1.22 P/Share
|
|
Sep 09
2025
|
Gail J Maderis |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+50.0%
|
$5,500
$1.22 P/Share
|
|
Sep 08
2025
|
James E Brown President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.41%
|
$10,000
$1.3 P/Share
|
|
Sep 08
2025
|
Timothy M. Papp Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
110,000
+20.31%
|
$110,000
$1.3 P/Share
|
|
Aug 22
2025
|
R Scott Asen > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,917
+0.22%
|
$5,917
$1.92 P/Share
|
|
Aug 21
2025
|
R Scott Asen > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
116,612
+4.19%
|
$116,612
$1.9 P/Share
|
|
Aug 20
2025
|
R Scott Asen > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
87,608
+8.28%
|
$87,608
$1.89 P/Share
|
|
Jul 11
2025
|
Timothy M. Papp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,659
+12.67%
|
-
|
|
Jul 11
2025
|
Norman Sussman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,425
+50.0%
|
-
|
|
Jul 11
2025
|
James E Brown President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
96,959
+26.18%
|
-
|